GLAXO
GlaxoSmithKline Pakistan Limited
340.01
Price (Rs.)
+ 10.50
Change (Rs.)
+ 3.19%
Change %
526.56K
Volume
Company Information
ISIN Code
PK0001301016
Sector
PHARMACEUTICALS
Industry
PHARMACEUTICALS
CEO
Erum Shakir Rahim
Website
Phone
922132315478
Company Size
1,708 employees
Address
35 - Dockyard Road, West Wharf, Karachi
About the Company
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).
Employee History
| Year | Number of Employees |
|---|---|
| 2025 | 1,606 |
| 2024 | 1,690 |
| 2023 | 1,708 |
| 2022 | 1,635 |
| 2021 | 1,771 |
Recent Announcements (Last 6 Months)
| Date | Title | Attachments |
|---|---|---|
| 2026-05-25 | (Re) Appointment of Chairperson and Chief Executive Officer | Image PDF |
| 2026-06-01 | Resignation of Non-Executive Director | Image PDF |
| 2026-06-08 | Resignation of Chief Financial Officer & Executive Director | Image PDF |
| 2026-08-03 | Appointment of Non-Executive Director | Image PDF |
| 2026-08-03 | Appointment of Interim/ Acting Chief Financial Officer | Image PDF |
| 2026-08-18 | Board Meeting | Image PDF |
| 2026-08-25 | Financial Results for the Quarter Ended June 30, 2026 | Image PDF |
| 2026-08-25 | Change in Book Closure Date | Image PDF |
| 2026-08-27 | Prior Publication of Notice of Interim Cash Dividend and Share Book Closure | Image PDF |
| 2026-08-28 | Notice of interim cash dividend and share book closure | Image PDF |
| 2026-08-28 | Appointment of Executive Director | Image PDF |
| 2026-09-03 | Appointment of Chief Financial Officer | Image PDF |
| 2026-08-28 | Transmission of Quarterly Report for the Period ended June 30, 2026 | Image PDF |
| 2026-09-11 | Credit of Interim Cash Dividend | Image PDF |
| 2026-09-15 | Shariah Disclosure for the Half Year ended June 30, 2026 | Image PDF |
| 2026-10-21 | Board Meeting Quarter 3-2026 | Image PDF |
| 2026-10-29 | Financial Results for the Quarter Ended September 30, 2026 | Image PDF |
| 2026-10-30 | Transmission of Quarterly Report for the Period Ended September 30, 2026 | Image PDF |
Insider Transactions
No insider transactions available.
Price History (Last 30 Days)
| Date | Price (Rs.) | Volume | Market Cap |
|---|---|---|---|
| 2026-11-05 | 340.01 | 526.56K | 108.28B |
| 2026-11-04 | 329.51 | 235.19K | 104.94B |
| 2026-11-03 | 317.65 | 18.77K | 101.16B |
| 2026-11-02 | 317.97 | 41.43K | 101.26B |
| 2026-10-30 | 319.39 | 102.13K | 101.72B |
| 2026-10-29 | 326.01 | 720.96K | 103.82B |
| 2026-10-28 | 315.00 | 56.27K | 100.32B |
| 2026-10-27 | 314.82 | 101.14K | 100.26B |
| 2026-10-26 | 307.31 | 51.45K | 97.87B |
| 2026-10-23 | 309.23 | 81.09K | 98.48B |
| 2026-10-22 | 310.22 | 31.68K | 98.79B |
| 2026-10-21 | 313.52 | 22.77K | 99.85B |
| 2026-10-20 | 315.05 | 110.04K | 100.33B |
| 2026-10-19 | 313.98 | 113.89K | 99.99B |
| 2026-10-16 | 312.45 | 13.7K | 99.51B |
| 2026-10-15 | 311.85 | 82.47K | 99.31B |
| 2026-10-14 | 312.44 | 57.51K | 99.5B |
| 2026-10-13 | 311.19 | 62.01K | 99.1B |
| 2026-10-12 | 312.00 | 63.98K | 99.36B |
| 2026-10-09 | 316.60 | 138.9K | 100.83B |
| 2026-10-08 | 312.85 | 54.66K | 99.63B |
| 2026-10-07 | 314.59 | 56.44K | 100.19B |
